Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142900 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142901 |
| CAS No | 29291-35-8 |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142902 |
| CAS No | 77313-99-6 |
| Mol.F. | C19H22N8O7 |
| Mol.Wt. | 474.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142903 |
| CAS No | NA |
| Mol.F. | C7H4N6O4 |
| Mol.Wt. | 236.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142904 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142905 |
| CAS No | NA |
| Mol.F. | C21H21N5O4 |
| Mol.Wt. | 407.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142906 |
| CAS No | NA |
| Mol.F. | C21H20N4O5 |
| Mol.Wt. | 408.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142907 |
| CAS No | NA |
| Mol.F. | C24H23N5O5 |
| Mol.Wt. | 461.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142908 |
| CAS No | NA |
| Mol.F. | C19H17N5O4 |
| Mol.Wt. | 379.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142909 |
| CAS No | NA |
| Mol.F. | C21H23N5O6 |
| Mol.Wt. | 441.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142910 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142911 |
| CAS No | NA |
| Mol.F. | C21H21N5O5 |
| Mol.Wt. | 423.43g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142912 |
| CAS No | NA |
| Mol.F. | C19H16N4O5 |
| Mol.Wt. | 380.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142913 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142914 |
| CAS No | NA |
| Mol.F. | C22H23N5O4 |
| Mol.Wt. | 421.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142915 |
| CAS No | NA |
| Mol.F. | C20H19N5O4 |
| Mol.Wt. | 393.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |